Mitoxantrone recalls
The FDA has published 1 recall involving Mitoxantrone since 2015. The latest was reported on 15 Apr 2015. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2015
Last 12 months0reported
Class I1100% of total
Ongoing0latest 15 Apr 2015
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 100%Class II 0 0%Class III 0 0%
Why mitoxantrone is recalled
Companies
By year
All mitoxantrone recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | MitoXANTRONE Injection, USP, (concentrate) 2 mg/mL recalled by HospiraMitoxantrone | Hospira | Potency & Assay | Nationwide |
Should you stop taking Mitoxantrone?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.